$334.10
-1.87-0.56%
Last update: 10:27 AM
15 minutes delayed
Comments
Loading...
Amgen
AMGNNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Amgen (NASDAQ:AMGN) Stock, Analyst Ratings, Price Targets, Forecasts
Amgen Inc has a consensus price target of $291.56 based on the ratings of 29 analysts. The high is $360 issued by TD Cowen on April 17, 2024. The low is $182 issued by Atlantic Equities on August 9, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, Argus Research, and RBC Capital on July 11, 2024, June 27, 2024, and June 14, 2024, respectively. With an average price target of $325 between Morgan Stanley, Argus Research, and RBC Capital, there's an implied -2.72% downside for Amgen Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Argus Research
RBC Capital
Mizuho
UBS
1calculated from analyst ratings
Analyst Ratings for Amgen
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/11/2024 | Buy Now | -9.31% | Morgan Stanley | Terence Flynn | $310 → $303 | Maintains | Equal-Weight | Get Alert |
| 06/27/2024 | Buy Now | 1.77% | Argus Research | David Toung | $300 → $340 | Maintains | Buy | Get Alert |
| 06/14/2024 | Buy Now | -0.63% | RBC Capital | Gregory Renza | $328 → $332 | Maintains | Outperform | Get Alert |
| 05/09/2024 | Buy Now | -29.66% | Mizuho | Salim Syed | $223 → $235 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | -1.83% | RBC Capital | Gregory Renza | $332 → $328 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | -7.21% | Morgan Stanley | Terence Flynn | $271 → $310 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | -8.11% | UBS | Colin Bristow | $284 → $307 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | William Blair | Matthew Phipps | — | Upgrade | Market Perform → Outperform | Get Alert |
| 05/03/2024 | Buy Now | 6.26% | BMO Capital | Evan David Seigerman | $336 → $355 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | -10.21% | Barclays | Carter Gould | $230 → $300 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 04/17/2024 | Buy Now | -15% | UBS | Colin Bristow | $314 → $284 | Maintains | Neutral | Get Alert |
| 04/17/2024 | Buy Now | 7.75% | TD Cowen | Yaron Weber | $370 → $360 | Maintains | Buy | Get Alert |
| 04/12/2024 | Buy Now | -4.22% | Truist Securities | Robyn Karnauskas | $320 → $320 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | Buy Now | -1.53% | RBC Capital | Gregory Renza | → $329 | Reiterates | Outperform → Outperform | Get Alert |
| 03/28/2024 | Buy Now | — | Raymond James | Gary Nachman | — | Reinstates | → Market Perform | Get Alert |
| 02/08/2024 | Buy Now | 4.76% | Goldman Sachs | Salveen Richter | $313 → $350 | Maintains | Buy | Get Alert |
| 02/07/2024 | Buy Now | -16.79% | Morgan Stanley | Terence Flynn | $281 → $278 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | Buy Now | -1.53% | RBC Capital | Gregory Renza | $303 → $329 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 4.76% | Goldman Sachs | Salveen Richter | $313 → $350 | Maintains | Buy | Get Alert |
| 02/01/2024 | Buy Now | 4.76% | Oppenheimer | Jay Olson | → $350 | Reiterates | Outperform → Outperform | Get Alert |
| 01/29/2024 | Buy Now | -6.02% | UBS | Colin Bristow | $315 → $314 | Maintains | Neutral | Get Alert |
| 12/21/2023 | Buy Now | -4.22% | Daiwa Capital | Narumi Nakagiri | → $320 | Upgrade | Neutral → Buy | Get Alert |
| 12/19/2023 | Buy Now | -2.42% | BMO Capital | Evan David Seigerman | $286 → $326 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/12/2023 | Buy Now | -10.21% | RBC Capital | Gregory Renza | $256 → $300 | Upgrade | Sector Perform → Outperform | Get Alert |
| 11/29/2023 | Buy Now | -4.22% | Truist Securities | Robyn Karnauskas | → $320 | Reiterates | Buy → Buy | Get Alert |
| 11/09/2023 | Buy Now | -28.17% | Deutsche Bank | James Shin | → $240 | Initiates | → Hold | Get Alert |
| 11/02/2023 | Buy Now | -23.38% | RBC Capital | Gregory Renza | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/02/2023 | Buy Now | -4.22% | Truist Securities | Robyn Karnauskas | → $320 | Upgrade | Hold → Buy | Get Alert |
| 11/02/2023 | Buy Now | -19.78% | UBS | Colin Bristow | $272 → $268 | Maintains | Neutral | Get Alert |
| 11/01/2023 | Buy Now | -23.38% | RBC Capital | Gregory Renza | $253 → $256 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | Buy Now | -12.9% | Morgan Stanley | Terence Flynn | $300 → $291 | Maintains | Equal-Weight | Get Alert |
| 10/25/2023 | Buy Now | -7.21% | Oppenheimer | Jay Olson | $300 → $310 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | -10.21% | Oppenheimer | Jay Olson | $290 → $300 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | -19.19% | JP Morgan | Chris Schott | → $270 | Reinstates | Neutral → Neutral | Get Alert |
| 10/17/2023 | Buy Now | -7.21% | Argus Research | David Toung | $280 → $310 | Maintains | Buy | Get Alert |
| 10/17/2023 | Buy Now | -10.21% | Morgan Stanley | Terence Flynn | → $300 | Reinstates | → Equal-Weight | Get Alert |
| 10/12/2023 | Buy Now | -7.21% | Jefferies | Michael Yee | $310 → $310 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2023 | Buy Now | -4.82% | Leerink Partners | David Risinger | $267 → $318 | Upgrade | Market Perform → Outperform | Get Alert |
| 10/11/2023 | Buy Now | -13.2% | B of A Securities | Geoff Meacham | → $290 | Reinstates | → Neutral | Get Alert |
| 10/09/2023 | Buy Now | -13.2% | Oppenheimer | Jay Olson | $280 → $290 | Maintains | Outperform | Get Alert |
| 09/18/2023 | Buy Now | -16.19% | Argus Research | David Toung | $260 → $280 | Maintains | Buy | Get Alert |
| 09/06/2023 | Buy Now | -4.22% | HSBC | Morten Herholdt | → $320 | Initiates | → Buy | Get Alert |
| 09/05/2023 | Buy Now | -22.18% | Truist Securities | Robyn Karnauskas | → $260 | Reiterates | Hold → Hold | Get Alert |
| 08/14/2023 | Buy Now | -7.21% | Jefferies | Michael Yee | $275 → $310 | Maintains | Buy | Get Alert |
| 08/14/2023 | Buy Now | -33.25% | Mizuho | Salim Syed | $214 → $223 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | -24.27% | RBC Capital | Gregory Renza | $250 → $253 | Maintains | Sector Perform | Get Alert |
| 07/25/2023 | Buy Now | -16.19% | Oppenheimer | Jay Olson | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 07/12/2023 | Buy Now | -40.14% | Credit Suisse | Trung Huynh | $220 → $200 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | -37.14% | Barclays | Carter Gould | $225 → $210 | Maintains | Underweight | Get Alert |
| 06/26/2023 | Buy Now | -22.18% | Argus Research | David Toung | $270 → $260 | Maintains | Buy | Get Alert |
| 05/18/2023 | Buy Now | -16.19% | Oppenheimer | Jay Olson | → $280 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2023 | Buy Now | -23.97% | RBC Capital | Gregory Renza | → $254 | Reiterates | → Sector Perform | Get Alert |
| 05/01/2023 | Buy Now | -32.65% | Barclays | Carter Gould | $227 → $225 | Maintains | Underweight | Get Alert |
| 04/28/2023 | Buy Now | -13.8% | Piper Sandler | Christopher Raymond | $293 → $288 | Maintains | Overweight | Get Alert |
| 04/24/2023 | Buy Now | -13.2% | Oppenheimer | Jay Olson | $292 → $290 | Maintains | Outperform | Get Alert |
| 04/14/2023 | Buy Now | -32.06% | Barclays | Carter Gould | $230 → $227 | Maintains | Underweight | Get Alert |
| 03/13/2023 | Buy Now | -20.68% | Wells Fargo | Mohit Bansal | $275 → $265 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/13/2023 | Buy Now | -22.18% | Truist Securities | Robyn Karnauskas | $280 → $260 | Maintains | Hold | Get Alert |
| 02/02/2023 | Buy Now | -20.08% | SVB Leerink | David Risinger | $282 → $267 | Maintains | Market Perform | Get Alert |
| 02/01/2023 | Buy Now | -17.69% | Wells Fargo | Mohit Bansal | $285 → $275 | Maintains | Equal-Weight | Get Alert |
| 02/01/2023 | Buy Now | -22.78% | RBC Capital | Gregory Renza | $268 → $258 | Maintains | Sector Perform | Get Alert |
| 02/01/2023 | Buy Now | -12% | Oppenheimer | Jay Olson | $312 → $294 | Maintains | Outperform | Get Alert |
| 02/01/2023 | Buy Now | -13.5% | Cowen & Co. | Yaron Weber | $307 → $289 | Maintains | Outperform | Get Alert |
| 02/01/2023 | Buy Now | -34.15% | Credit Suisse | Trung Huynh | $240 → $220 | Maintains | Underperform | Get Alert |
| 02/01/2023 | Buy Now | -24.27% | BMO Capital | Evan David Seigerman | $276 → $253 | Maintains | Market Perform | Get Alert |
| 02/01/2023 | Buy Now | -31.16% | Barclays | Carter Gould | $240 → $230 | Maintains | Underweight | Get Alert |
| 01/19/2023 | Buy Now | -12.3% | Piper Sandler | Christopher Raymond | $299 → $293 | Maintains | Overweight | Get Alert |
| 01/18/2023 | Buy Now | -28.17% | Barclays | Carter Gould | $234 → $240 | Maintains | Underweight | Get Alert |
| 01/03/2023 | Buy Now | -14.7% | Wells Fargo | Mohit Bansal | $250 → $285 | Maintains | Equal-Weight | Get Alert |
| 12/22/2022 | Buy Now | -15.59% | SVB Leerink | David Risinger | $256 → $282 | Maintains | Market Perform | Get Alert |
| 12/13/2022 | Buy Now | -10.51% | Piper Sandler | Christopher Raymond | $297 → $299 | Maintains | Overweight | Get Alert |
| 12/06/2022 | Buy Now | -7.21% | Oppenheimer | Jay Olson | $300 → $310 | Maintains | Outperform | Get Alert |
| 11/18/2022 | Buy Now | -28.17% | Credit Suisse | Trung Huynh | → $240 | Initiates | → Underperform | Get Alert |
| 11/04/2022 | Buy Now | -28.17% | RBC Capital | Gregory Renza | $235 → $240 | Maintains | Sector Perform | Get Alert |
| 11/04/2022 | Buy Now | -15.59% | Morgan Stanley | Matthew Harrison | $279 → $282 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | -16.79% | Piper Sandler | Christopher Raymond | $265 → $278 | Maintains | Overweight | Get Alert |
| 10/31/2022 | Buy Now | -29.96% | Barclays | Carter Gould | → $234 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/12/2022 | Buy Now | -29.96% | Barclays | Carter Gould | $236 → $234 | Maintains | Equal-Weight | Get Alert |
| 10/11/2022 | Buy Now | -16.49% | Morgan Stanley | Matthew Harrison | $257 → $279 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/09/2022 | Buy Now | -45.53% | Atlantic Equities | Steve Chesney | $190 → $182 | Maintains | Underweight | Get Alert |
| 08/05/2022 | Buy Now | -29.36% | RBC Capital | Kennen MacKay | $224 → $236 | Maintains | Sector Perform | Get Alert |
| 08/05/2022 | Buy Now | -20.68% | Piper Sandler | Christopher Raymond | $260 → $265 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | -24.27% | Morgan Stanley | Matthew Harrison | $239 → $253 | Maintains | Equal-Weight | Get Alert |
| 06/01/2022 | Buy Now | -13.2% | Oppenheimer | Jay Olson | $285 → $290 | Maintains | Outperform | Get Alert |
| 05/23/2022 | Buy Now | -23.38% | SVB Leerink | David Risinger | → $256 | Initiates | → Market Perform | Get Alert |
| 05/10/2022 | Buy Now | -37.74% | Mizuho | Salim Syed | $202 → $208 | Maintains | Neutral | Get Alert |
| 04/28/2022 | Buy Now | -33.25% | RBC Capital | Gregory Renza | $218 → $223 | Maintains | Sector Perform | Get Alert |
| 04/28/2022 | Buy Now | -27.27% | BMO Capital | Evan Seigerman | $263 → $243 | Maintains | Market Perform | Get Alert |
| 04/28/2022 | Buy Now | -22.18% | Piper Sandler | Christopher Raymond | $255 → $260 | Maintains | Overweight | Get Alert |
| 04/12/2022 | Buy Now | -29.06% | Morgan Stanley | Matthew Harrison | $238 → $237 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | Buy Now | -29.36% | Barclays | Carter Gould | $233 → $236 | Maintains | Equal-Weight | Get Alert |
| 02/09/2022 | Buy Now | -28.76% | Morgan Stanley | Matthew Harrison | $235 → $238 | Maintains | Equal-Weight | Get Alert |
| 02/09/2022 | Buy Now | -25.17% | Wells Fargo | Mohit Bansal | $210 → $250 | Maintains | Equal-Weight | Get Alert |
| 02/09/2022 | Buy Now | -30.26% | Barclays | Carter Gould | $228 → $233 | Maintains | Equal-Weight | Get Alert |
| 02/09/2022 | Buy Now | -14.7% | Oppenheimer | Jay Olson | $272 → $285 | Maintains | Outperform | Get Alert |
| 01/05/2022 | Buy Now | -23.68% | B of A Securities | Geoff Meacham | $285 → $255 | Downgrade | Buy → Neutral | Get Alert |
| 12/21/2021 | Buy Now | -34.75% | RBC Capital | Kennen MacKay | $216 → $218 | Maintains | Sector Perform | Get Alert |
| 12/09/2021 | Buy Now | -37.14% | Wells Fargo | Mohit Bansal | — | Initiates | → Equal-Weight | Get Alert |
| 12/06/2021 | Buy Now | -22.78% | Goldman Sachs | Salveen Richter | — | Initiates | → Buy | Get Alert |
| 11/22/2021 | Buy Now | -41.93% | Mizuho | Salim Syed | — | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Amgen (AMGN) stock?
The latest price target for Amgen (NASDAQ:AMGN) was reported by Morgan Stanley on July 11, 2024. The analyst firm set a price target for $303.00 expecting AMGN to fall to within 12 months (a possible -9.31% downside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amgen (AMGN)?
The latest analyst rating for Amgen (NASDAQ:AMGN) was provided by Morgan Stanley, and Amgen maintained their equal-weight rating.
When was the last upgrade for Amgen (AMGN)?
The last upgrade for Amgen Inc happened on May 3, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Amgen Inc.
When was the last downgrade for Amgen (AMGN)?
The last downgrade for Amgen Inc happened on October 31, 2022 when Barclays changed their price target from N/A to $234 for Amgen Inc.
When is the next analyst rating going to be posted or updated for Amgen (AMGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amgen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amgen was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.
Is the Analyst Rating Amgen (AMGN) correct?
While ratings are subjective and will change, the latest Amgen (AMGN) rating was a maintained with a price target of $310.00 to $303.00. The current price Amgen (AMGN) is trading at is $334.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.